Search Results for keywords:"National Institutes of Health"

The National Institute of Neurological Disorders and Stroke (NINDS) has scheduled several meetings to discuss grant applications and cooperative agreements. These meetings are part of a review process and will be closed to the public to protect confidential and personal information. The meetings, occurring from April 1 to April 4, 2025, will be conducted virtually. Contact information for the scientific review officers overseeing each meeting is also provided.

The National Institute of Dental & Craniofacial Research announced that it will hold a closed meeting on April 22, 2025, from 10:00 a.m. to 6:00 p.m. This virtual meeting is part of a review panel focusing on grant applications for research on Organs-on-a-Chip in dental, oral, and craniofacial studies. The meeting will be closed to the public to protect confidential information and personal privacy. Dr. Jingshan Chen is the contact person for further information regarding this event.

The National Institute on Aging announced changes to its upcoming meeting schedule for the National Advisory Council on Aging. Originally planned as an in-person event on May 13-14, 2025, the meeting will now be held virtually. The meeting times have been adjusted to 1 p.m.-3 p.m. on May 13 and from 10 a.m.-1 p.m. on May 14. Portions of the meeting will not be open to the public.

The National Institutes of Health announced a change to the Bacterial-Host Interactions Study Section meeting schedule. Originally set to begin at 8:30 a.m. on April 10, 2025, the meeting will now start at 9:00 a.m. The meeting will take place as planned between April 10 and April 11, 2025, at the NIH in Bethesda, MD, and it will be closed to the public. This update was published in the Federal Register on March 31, 2025.

In accordance with the Federal Advisory Committee Act, the National Institutes of Health (NIH) announced that several meetings of the Center for Scientific Review will be held virtually. These meetings, taking place between March 19 and March 24, 2021, are closed to the public due to the sensitive nature of the discussions, which include evaluating grant applications and potential disclosure of confidential materials. The subject matter of the meetings ranges from drug discovery and neurodegenerative disorders to HIV/AIDS prevention and treatment, with various scientific review officers assigned to manage the sessions. These sessions aim to review and evaluate various grant proposals, ensuring that personal privacy and proprietary information remain protected.

The National Institutes of Health (NIH) has announced a series of closed meetings as part of the Center for Scientific Review. The meetings, which take place in February 2021, are intended to review and evaluate grant applications in various scientific fields including musculoskeletal tissue engineering, neuroscience, and diabetes metabolism. These meetings will be held virtually at the NIH headquarters in Bethesda, Maryland, and are closed to the public to protect confidential information and personal privacy. Each meeting is facilitated by a designated Scientific Review Officer.

The National Institutes of Health (NIH) has announced a closed meeting of the Center for Scientific Review Special Emphasis Panel focused on the Neurobiology of Pain and Itch. The meeting will take place virtually on January 6, 2025, from 11:00 a.m. to 2:00 p.m. During this meeting, grant applications will be reviewed and evaluated, and it will be closed to the public to protect confidential information and maintain privacy. The contact person for this meeting is Dr. Anne-Sophie Marie Lucie Wattiez, a Scientific Review Officer at the NIH.

The National Institutes of Health announced a series of closed meetings for reviewing grant applications. These meetings will take place virtually from February 11 to February 19, 2021, and cover various topics such as neuroscience, immunology, bioengineering, and public health. The meetings are closed to the public to protect confidential information and personal privacy associated with the grant applications. They were announced in compliance with federal regulations to maintain transparency in governmental advisory activities.

The National Institutes of Health (NIH) is offering a new invention for licensing, aiming to quickly commercialize results from government-funded research. This invention involves a vaccine technology, developed by NIH, that uses adenovirus type 4 to stimulate an immune response against SARS-CoV-2. The vaccine offers benefits like durable immunity and ease of distribution and is available for companies to license. Interested parties can obtain further information and discuss collaboration opportunities by contacting Chris Kornak from the NIH.

The National Institute on Aging has announced a change to the dates of one of its meetings initially scheduled for January 31, 2025. The meeting, which is part of a Special Emphasis Panel, will now take place on May 7, 2025, in Rockville, Maryland. This information amends what was previously published in the Federal Register on December 30, 2024. The meeting will be closed to the public.